Ole Andreas Halvorsen - Viking Global Investors Portfolio Holdings (Jun 30, 2025)
As of Jun 30, 2025, the Viking Global Investors portfolio holdings is valued at approximately $34.59B, featuring 83 publicly traded holdings. This in-depth profile highlights the top investments led by BANK AMERICA CORP (BAC), SCHWAB CHARLES CORP (SCHW), CAPITAL ONE FINL CORP (COF), JPMORGAN CHASE & CO. (JPM), US BANCORP DEL (USB), and others based on the company's latest SEC filings reported on Aug 14, 2025. Explore insights into portfolio composition, sector allocation, and recent trade activity.
Viking Global Investors’s stock portfolio spans 83 holdings across 10 different sectors, with a total market value of $34.59B. The Financial Services sector represents the largest allocation, while the top holdings account for nearly 18% of the total portfolio value. BANK AMERICA CORP remains single largest position at 4.3% of all equity investments.
Trends by sector
Investment Adjustments from Previous Filing
Viking Global Investors Holdings
Symbol | Portfolio % | Total Value |
---|---|---|
ITGR INTEGER HLDGS CORP | 0.46% | $157,889,176 |
AIG AMERICAN INTL GROUP INC | 0.45% | $155,413,038 |
JCI JOHNSON CTLS INTL PLC | 0.44% | $153,234,763 |
AS AMER SPORTS INC | 0.43% | $150,413,955 |
APP APPLOVIN CORP | 0.38% | $130,570,388 |
MASI MASIMO CORP | 0.37% | $129,096,402 |
NAMSW NEWAMSTERDAM PHARMA COMPANY | 0.37% | $126,381,251 |
RYAN RYAN SPECIALTY HOLDINGS INC | 0.28% | $96,054,028 |
RPRX ROYALTY PHARMA PLC | 0.27% | $93,586,484 |
UBS UBS GROUP AG | 0.25% | $87,320,010 |
MOH MOLINA HEALTHCARE INC | 0.23% | $79,664,716 |
LAB STANDARD BIOTOOLS INC | 0.20% | $70,381,404 |
ORIC ORIC PHARMACEUTICALS INC | 0.19% | $66,712,905 |
PHVS PHARVARIS N V | 0.19% | $64,298,256 |
SION SIONNA THERAPEUTICS INC | 0.16% | $55,436,390 |
59267L107 METSERA INC | 0.13% | $45,992,611 |
DNA GINKGO BIOWORKS HOLDINGS INC | 0.12% | $40,242,690 |
INBX INHIBRX BIOSCIENCES INC | 0.07% | $25,510,550 |
HQY HEALTHEQUITY INC | 0.07% | $23,020,591 |
ESTA ESTABLISHMENT LABS HLDGS INC | 0.04% | $14,669,390 |
TRVI TREVI THERAPEUTICS INC | 0.02% | $8,440,210 |
PEPG PEPGEN INC | 0.00% | $1,645,502 |
RLYB RALLYBIO CORP | 0.00% | $1,417,835 |